Segall Bryant & Hamill
RDY icon

Segall Bryant & Hamill’s Dr. Reddy's Laboratories RDY Stock Holding History

Segall Bryant & Hamill’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-45,100
Closed -$595K – 624
2025
Q1 		$595K Hold
45,100
– – 0.01% 542
2024
Q4 		$712K Buy
+45,100
New +$678K 0.01% 534
2023
Q3 		– Sell
-33,500
Closed -$423K – 655
2023
Q2 		$423K Sell
33,500
-9,500
-22% -$111K ﹤0.01% 590
2023
Q1 		$489K Buy
43,000
+3,500
+9% +$37.8K 0.01% 577
2022
Q4 		$408K Buy
+39,500
New +$426K ﹤0.01% 600

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Segall Bryant & Hamill's RDY Position: Q2 2025 in Review

Segall Bryant & Hamill sold out of Dr. Reddy's Laboratories (RDY) in Q2 2025, closing a stake of 45,100 shares — an estimated $595K sold.

Segall Bryant & Hamill first reported a position in RDY in Q4 2022 and held it in 5 quarters. The position peaked at $712K in Q4 2024. 243 funds tracked by Wall St. Rank hold RDY as of Q2 2025.

  • Segall Bryant & Hamill reported no remaining Dr. Reddy's Laboratories position as of Q2 2025 after selling out during the quarter.
  • Segall Bryant & Hamill sold 45,100 Dr. Reddy's Laboratories shares in Q2 2025, an estimated $595K.
  • Segall Bryant & Hamill first reported a position in Dr. Reddy's Laboratories in Q4 2022 and held it in 5 quarters.
  • Segall Bryant & Hamill's Dr. Reddy's Laboratories position peaked at $712K in Q4 2024.
  • 243 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2025.

Based on Segall Bryant & Hamill's 13F filing for Q2 2025, filed 12 Aug 2025.